iifl-logo-icon 1

SMS Pharmaceuticals Ltd Share Price

246.32
(0.90%)
Jul 16, 2024|03:32:25 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open245
  • Day's High253
  • 52 Wk High263.73
  • Prev. Close244.13
  • Day's Low245
  • 52 Wk Low100.8
  • Turnover (lac)295.76
  • P/E41.88
  • Face Value1
  • Book Value64.33
  • EPS5.84
  • Mkt. Cap (Cr.)2,085.15
  • Div. Yield0
No Records Found

SMS Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

245

Prev. Close

244.13

Turnover(Lac.)

295.76

Day's High

253

Day's Low

245

52 Week's High

263.73

52 Week's Low

100.8

Book Value

64.33

Face Value

1

Mkt Cap (₹ Cr.)

2,085.15

P/E

41.88

EPS

5.84

Divi. Yield

0

SMS Pharmaceuticals Ltd Corporate Action

22 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

8 Aug 2023

12:00 AM

AGM

Announcement Date: 08 Aug, 2023

arrow

13 Feb 2024

12:00 AM

EGM

arrow

8 Aug 2023

12:00 AM

BookCloser

arrow

25 May 2023

12:00 AM

Dividend

Dividend Amount: 0.3

Record Date: 22 Sep, 2023

arrow

SMS Pharmaceuticals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

SMS Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

16 Jul, 2024|01:08 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 64.67%

Foreign: 0.00%

Indian: 64.67%

Non-Promoter- 2.30%

Institutions: 2.30%

Non-Institutions: 33.02%

Custodian: 0.00%

Share Price

SMS Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

8.47

8.47

8.47

8.47

Preference Capital

0

0

0

0

Reserves

486.63

485.3

419.76

358.96

Net Worth

495.1

493.77

428.23

367.43

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

563.17

411.94

462.67

438.12

yoy growth (%)

36.71

-10.96

5.6

-27.36

Raw materials

-339.99

-246.36

-289.89

-295.84

As % of sales

60.37

59.8

62.65

67.52

Employee costs

-41.17

-39.35

-32.8

-26.92

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

91.11

50.75

60.34

41.58

Depreciation

-22.28

-22.06

-19.89

-19.17

Tax paid

-30.15

-18.06

-19.89

-5.96

Working capital

60.27

35.89

36.48

-52.78

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

36.71

-10.96

5.6

-27.36

Op profit growth

51.54

-14.37

24.78

-16.14

EBIT growth

62.43

-16.96

32.87

-22.21

Net profit growth

86.5

-19.19

13.58

-14.46

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

709.26

522.05

519.87

563.18

411.95

Excise Duty

0

0

0

0

0

Net Sales

709.26

522.05

519.87

563.18

411.95

Other Operating Income

0

0

0

0

0

Other Income

4.46

4.91

5.2

3.45

5.11

SMS Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,586.2

124.663,80,450.55867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,517.2

32.961,22,423.771,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,575.4

77.071,21,461.175310.652,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,188

34.771,19,530.541,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,794.75

26.451,13,324.081,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT SMS Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

P Ramesh Babu

Independent Director

P Sarath Kumar

Independent Director

Thummala Neelaveni

Independent Director

Shravan Kudaravalli

Independent Director

Sarvepalli Srinivas

Executive Director

Vamsi Krishna Potluri

Company Sec. & Compli. Officer

Thirumalesh Tumma

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

SMS Pharmaceuticals Limited is a Public company incorporated in December 14, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa in Vijayanagaram Dist. Its business activity is a single primary business segment of Bulk Drugs. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities.During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24.During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s. VKT Pharma Private Limited. With this the said company has become an associate company. The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced. The Company has not having any subsidiaries.During the year 2015-16, the Company had sub divided the face value of share of Rs 10/- each into face value of Rs 1/- of each with record date of 18th December 2015.During FY 2015-16, the Board has approved the Draft Scheme of Arrangement for Demerger of Semi Regulated Units (Unit - I, IV & V) along with other Assets to transfer the same to SMS Lifesciences India Limited (Resulting Company), with an object
Read More

Company FAQs

What is the SMS Pharmaceuticals Ltd share price today?

Down Arrow

The SMS Pharmaceuticals Ltd shares price on N/A is Rs.₹246.7 today.

What is the Market Cap of SMS Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of SMS Pharmaceuticals Ltd is ₹2088.37 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of SMS Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of SMS Pharmaceuticals Ltd is 41.88 and 3.63 as of 16 Jul ‘24

What is the 52 Week High and Low of SMS Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a SMS Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of SMS Pharmaceuticals Ltd is ₹100.72 and ₹265 as of 16 Jul ‘24

What is the CAGR of SMS Pharmaceuticals Ltd?

Down Arrow

SMS Pharmaceuticals Ltd's CAGR for 5 Years at 37.87%, 3 Years at 11.80%, 1 Year at 139.57%, 6 Month at 89.06%, 3 Month at 20.77% and 1 Month at 17.49%.

What is the shareholding pattern of SMS Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of SMS Pharmaceuticals Ltd is as follows:
Promoters - 64.67 %
Institutions - 2.30 %
Public - 33.03 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.